12 Health Care Stocks Moving In Thursday's Pre-Market Session
Portfolio Pulse from Benzinga Insights
12 health care stocks experienced significant price movements during Thursday's pre-market session, with 6 gainers and 6 losers. Notable gainers include SCWorx, Adial Pharmaceuticals, and Scilex Holding, while Mersana Therapeutics, Bone Biologics, and OncoSec Medical were among the losers.
June 15, 2023 | 1:07 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Adial Pharmaceuticals stock increased by 16.43% to $0.27, with a market value of $7.6 million.
Adial Pharmaceuticals' 16.43% increase in stock price during the pre-market session indicates a positive short-term impact on the stock. The significant price movement suggests increased investor interest and demand for the stock.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
POSITIVE IMPACT
Scilex Holding stock increased by 15.57% to $8.61, with a market cap of $1.2 billion.
Scilex Holding's 15.57% increase in stock price during the pre-market session indicates a positive short-term impact on the stock. The significant price movement suggests increased investor interest and demand for the stock.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
POSITIVE IMPACT
SCWorx shares moved upwards by 40.7% to $0.31 during Thursday's pre-market session, with a market cap of $4.0 million.
SCWorx's 40.7% increase in share price during the pre-market session indicates a positive short-term impact on the stock. The significant price movement suggests increased investor interest and demand for the stock.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
NEGATIVE IMPACT
Bone Biologics stock fell 50.9% to $1.93, with a market cap of $1.0 million.
Bone Biologics' 50.9% decrease in stock price during the pre-market session indicates a negative short-term impact on the stock. The significant price movement suggests decreased investor interest and demand for the stock.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
NEGATIVE IMPACT
Mersana Therapeutics shares fell 58.0% to $4.01 during Thursday's pre-market session, with a market cap of $458.6 million.
Mersana Therapeutics' 58.0% decrease in share price during the pre-market session indicates a negative short-term impact on the stock. The significant price movement suggests decreased investor interest and demand for the stock.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
NEGATIVE IMPACT
OncoSec Medical shares declined by 48.01% to $0.22, with a market cap of $1.3 million.
OncoSec Medical's 48.01% decrease in share price during the pre-market session indicates a negative short-term impact on the stock. The significant price movement suggests decreased investor interest and demand for the stock.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100